Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
Journal
Frontiers in Systems Neuroscience
Date Issued
December 13, 2021
Author(s)
DOI
10.3389/fnsys.2021.782399
Abstract
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder for which there are no effective treatments. This review examines the latest evidence of a novel and newly introduced perspective, which focuses on the restoration of gamma oscillations and investigates their potential role in the treatment of AD. Gamma brain activity (∼25–100 Hz) has been well-known for its role in cognitive function, including memory, and it is fundamental for healthy brain activity and intra-brain communication. Aberrant gamma oscillations have been observed in both mice AD models and human AD patients. A recent line of work demonstrated that gamma entrainment, through auditory and visual sensory stimulation, can effectively attenuate AD pathology and improve cognitive function in mice models of the disease. The first evidence from AD patients indicate that gamma entrainment therapy can reduce loss of functional connectivity and brain atrophy, improve cognitive function, and ameliorate several pathological markers of the disease. Even though research is still in its infancy, evidence suggests that gamma-based therapy may have a disease-modifying effect and has signified a new and promising era in AD research.
File(s)![Thumbnail Image]()
Name
fnsys-15-782399.pdf
Size
268.22 KB
Format
Adobe PDF
Checksum (MD5)
769f54d73cb6defab4026a0edb77b236